1,101
Views
19
CrossRef citations to date
0
Altmetric
Research-article

Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab’)2 and cell penetrating peptide for improved therapeutic effect on hepatocellular carcinoma

, , , &
Pages 1076-1084 | Received 21 Jun 2017, Accepted 23 Jul 2017, Published online: 04 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Samaneh Mohammadi, Parvin Zakeri-Milani, Nasim Golkar, Samad Mussa Farkhani, Ali Shirani, Javid Shahbazi Mojarrad, Ali Nokhodchi & Hadi Valizadeh. (2018) Synthesis and cellular characterization of various nano-assemblies of cell penetrating peptide-epirubicin-polyglutamate conjugates for the enhancement of antitumor activity. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1572-1585.
Read now
Mehdi Soleymani-Goloujeh, Ali Nokhodchi, Mehri Niazi, Saeedeh Najafi-Hajivar, Javid Shahbazi-Mojarrad, Nosratollah Zarghami, Parvin Zakeri-Milani, Ali Mohammadi, Mohammad Karimi & Hadi Valizadeh. (2018) Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 91-103.
Read now
Afreen Usmani, Anuradha Mishra & Mohd Ahmad. (2018) Nanomedicines: a theranostic approach for hepatocellular carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 46:4, pages 680-690.
Read now

Articles from other publishers (16)

Leonard Kaps, María José Limeres, Paul Schneider, Malin Svensson, Yanira Zeyn, Silvia Fraude, Maximiliano L. Cacicedo, Peter R. Galle, Stephan Gehring & Matthias Bros. (2023) Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications. International Journal of Molecular Sciences 24:14, pages 11869.
Crossref
Cheng Jin, Ling Bai & Shuangquan Wang. (2022) Multifunctional nanoparticles for targeting liver cancer stem cells and efficient endocytosis. Chemical Papers 77:3, pages 1395-1403.
Crossref
Bruno Rodrigues Arruda, Maria Gabriela Araújo Mendes, Paulo George Cavalcante de Freitas, Alice Vitoria Frota Reis, Thayane Soares Lima, Luiziana Cavalcante Costa Fernandes Crisóstomo, Karina Alexandre Barros Nogueira, Cláudia Pessoa, Raquel Petrilli & Josimar O. Eloy. (2023) Nanocarriers for delivery of taxanes: A review on physicochemical and biological aspects. Journal of Drug Delivery Science and Technology 80, pages 104070.
Crossref
Ülo LangelÜlo Langel. 2023. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides 469 541 .
Vikas, Hemendra Kumar Sahu, Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya & Madaswamy S Muthu. (2022) Dual-receptor-targeted nanomedicines: emerging trends and advances in lung cancer therapeutics. Nanomedicine 17:19, pages 1375-1395.
Crossref
Shun‐Yu Wu, Fu‐Gen Wu & Xiaoyuan Chen. (2022) Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 34:24, pages 2109210.
Crossref
Eric Savier, Pierre Tuffery, Heriberto Bruzzoni-Giovanelli & Angelita Rebollo. 2022. Cell Penetrating Peptides. Cell Penetrating Peptides 413 427 .
Mohamed Fawzi Kabil, Maha Nasr & Ibrahim M. El-Sherbiny. (2021) Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 9-37.
Crossref
Alireza Shoari, Raheleh Tooyserkani, Mehdi Tahmasebi & Dennis W. P. M. Löwik. (2021) Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade. Pharmaceutics 13:9, pages 1391.
Crossref
Ana Rita Garizo, Flávia Castro, Cláudia Martins, Andreia Almeida, Tiago P. Dias, Fábio Fernardes, Cristina C. Barrias, Nuno Bernardes, Arsénio M. Fialho & Bruno Sarmento. (2021) p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer. Journal of Controlled Release 337, pages 329-342.
Crossref
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar & Md Nurunnabi. (2021) Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 9:14, pages 4821-4842.
Crossref
Xiaoyu Deng, Qinghua Bi, Shihan Chen, Xianhua Chen, Shuhui Li, Zhaoyang Zhong, Wei Guo, Xiaohui Li, Youcai Deng & Yao Yang. (2021) Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 7.
Crossref
Rostislav A. Petrov, Sofiia R. Mefedova, Emil Yu. Yamansarov, Svetlana Yu. Maklakova, Dmitrii A. Grishin, Elena V. Lopatukhina, Olga Y. Burenina, Anton V. Lopukhov, Sergey V. Kovalev, Yury V. Timchenko, Evgenia E. Ondar, Yan A. Ivanenkov, Sergei A. Evteev, Alexander N. Vaneev, Roman V. Timoshenko, Natalia L. Klyachko, Alexander S. Erofeev, Petr V. Gorelkin, Elena K. Beloglazkina & Alexander G. Majouga. (2020) New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma. Molecular Pharmaceutics 18:1, pages 461-468.
Crossref
Nuno Vale, Diana Duarte, Sara Silva, Ana Salomé Correia, Bárbara Costa, Maria João Gouveia & Abigail Ferreira. (2020) Cell-penetrating peptides in oncologic pharmacotherapy: A review. Pharmacological Research 162, pages 105231.
Crossref
James T. Oswald, Haritosh Patel, Daid Khan, Ninweh N. Jeorje, Hossein Golzar, Erin L. Oswald & Shirley Tang. (2020) Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells. Current Pharmaceutical Design 26:17, pages 2057-2071.
Crossref
Sara Silva, António Almeida & Nuno Vale. (2019) Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review. Biomolecules 9:1, pages 22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.